Staphylococcus aureus in lower respiratory infections: clinical relevance of antimicrobial resistance.
Staphylococcus aureus is the most common cause of nosocomial infections and is responsible for many community-acquired infections. Of concern is the increase in resistance to oxacillin (methicillin), with rates as high as 60% in some countries and in some intensive care units. Most of these strains are resistant to other antibacterials. Lately, strains with reduced susceptibility to glycopeptides have been reported.
Shah
P M
PM
Klinikum der J.W. Goethe Universitaet, Zentrum der Inneren Medizin, Schwerpunkt Infektiologie, D-60590 Frankfurt am Main, Germany. shah@em.uni-frankfurt.de
D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology*; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy / Q000382:microbiology*; D008826:Microbial Sensitivity Tests; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000187:drug effects*